MELK is not necessary for the proliferation of basal-like breast cancer cells
Hai‐Tsang Huang(Broad Institute), Nathanael S. Gray(Stanford University), Behnam Nabet(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Hilary McLauchlan(University of Dundee), Sirano Dhe‐Paganon(University of Toronto), Michael J. Eck(Harvard University), Justin M. Roberts(Dana-Farber Cancer Institute), Jean J. Zhao(Harvard University), Baishan Jiang(Wuhan University), Jennifer L. Moran(Broad Institute), Shiva Dastjerdi(Dana-Farber Cancer Institute), Hyuk‐Soo Seo(Dana-Farber Cancer Institute), Dennis L. Buckley(Novartis (United States)), Qing Li(Jinzhou Medical University), Yubao Wang(Albert Einstein College of Medicine), Tinghu Zhang(Stanford University), Georg E. Winter(CeMM Research Center for Molecular Medicine), James E. Bradner(Novartis (China)), Joshiawa Paulk(Novartis (United States))
Cited by 194
Related Papers
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
Biological insights from 108 schizophrenia-associated genetic loci
|Nature|2014|8.1k
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
|New England Journal of Medicine|2014|3.5k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
Identification of common genetic risk variants for autism spectrum disorder
|Nature Genetics|2019|2.6k